Cecilia Monge

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma”.

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

The Oncologist(2022)10.1093/oncolo/oyab073

N/A

1.5DataRank · unranked

44 citations

Erica C. Pehrsson, Changqing Xie, Austin G. Duffy, Donna Mabry, Bradford J. Wood +10 more

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005640

N/A

1.4DataRank · unranked

72 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang +15 more

Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma

PLoS ONE(2022)10.1371/journal.pone.0277407

N/A

0.528DataRank · unranked

9 citations

Joanna H. Shih, Joon‐Yong Chung, Jennifer Jones, Atoosa Rabiee, Cecilia Monge +14 more

Lineage and ecology define liver tumor evolution in response to treatment

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101394

N/A

0.503DataRank · unranked

11 citations

Limin Wang, Marshonna Forgues, Shay Behrens, Amanda J. Craig, Meng Liu +9 more

VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008079

N/A

0.470DataRank · unranked

11 citations

Yuta Myojin, Cecilia Monge, Changqing Xie, Donna Mabry Hrones, Bradford J. Wood +7 more

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma

Cancer Medicine(2024)10.1002/cam4.6912

N/A

0.450DataRank · unranked

12 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Gagandeep Brar +12 more

WNT and TGF-Beta Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic/Latino Populations

Cancers(2024)10.3390/cancers16233903

N/A

0DataRank · unranked

25 citations

Brigette Waldrup, Francisco Carranza, Enrique Velazquez‐Villarreal, Cecilia Monge

Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United States

Journal of Racial and Ethnic Health Disparities(2024)10.1007/s40615-024-02178-8

N/A

0DataRank · unranked

10 citations

Tim F. Greten, Cecilia Monge, Gabriela Arroyo Figueroa

Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy

La radiologia medica(2024)10.1007/s11547-024-01937-1

N/A

0DataRank · unranked

2 citations

Nicole Varble, Tabea Borde, Andrew S. Mikhail, Michael Kassin, Elliot Levy +11 more

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients

Cancer Cell(2025)10.1016/j.ccell.2025.02.010

N/A

0DataRank · unranked

48 citations

Antonin Lévy, Ai-Ling Tian, Xuehan Huang, Guoxin Cai, Marine Fidelle +56 more

Detecting PI3K and TP53 Pathway Disruptions in Early‐Onset Colorectal Cancer Among Hispanic/Latino Patients

Cancer Medicine(2025)10.1002/cam4.70791

N/A

0DataRank · unranked

19 citations

Brigette Waldrup, Sophia Manjarrez, Francisco Carranza, Enrique Velazquez‐Villarreal, Cecilia Monge

Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer

Cancers(2025)10.3390/cancers17071093

N/A

0DataRank · unranked

16 citations

Brigette Waldrup, Francisco Carranza, Enrique Velazquez‐Villarreal, Cecilia Monge

Barriers and Opportunities for Cancer Clinical Trials in Low- and Middle-Income Countries

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.7733

N/A

0DataRank · unranked

13 citations

Nina R. Goodman, A. Chtourou, Annette Galassi, Cecilia Monge, Mishka Kohli Cira +5 more

Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations

Cancers(2025)10.3390/cancers17081325

N/A

0DataRank · unranked

12 citations

Brigette Waldrup, Francisco Carranza, Enrique Velazquez‐Villarreal, Cecilia Monge

Molecular Alterations in TP53, WNT, PI3K, TGF-Beta, and RTK/RAS Pathways in Gastric Cancer Among Ethnically Heterogeneous Cohorts

Cancers(2025)10.3390/cancers17071075

N/A

0DataRank · unranked

11 citations

Brigette Waldrup, Francisco Carranza, Enrique Velazquez‐Villarreal, Cecilia Monge

Comparative Genomic Analysis of Key Oncogenic Pathways in Hepatocellular Carcinoma Among Diverse Populations

Cancers(2025)10.3390/cancers17081309

N/A

0DataRank · unranked

8 citations

Brigette Waldrup, Francisco Carranza, Enrique Velazquez‐Villarreal, Cecilia Monge

Pathway-Specific Genomic Alterations in Pancreatic Cancer Across Populations at Risk

International Journal of Molecular Sciences(2025)10.3390/ijms26167695

N/A

0DataRank · unranked

4 citations

Brigette Waldrup, Francisco Carranza, Sophia Manjarrez, Enrique Velazquez‐Villarreal, Cecilia Monge

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma(2021)10.2147/jhc.s311496

N/A

0DataRank · unranked

18 citations

Changqing Xie, Seth M. Steinberg, Tim F. Greten, Cecilia Monge

A summary of the National Cancer Institute Think Tank on Advancing Gastric Cancer Prevention

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf172

N/A

0DataRank · unranked

2 citations

Christian C. Abnet, Jeremy L. Davis, Cecilia Monge, Tram Kim Lam, Satish Gopal +8 more

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Archives of cardiovascular diseases(2022)10.1016/j.acvd.2022.03.003

N/A

0DataRank · unranked

40 citations

Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim S. Hayek, Aarti Asnani +61 more

The current landscape of therapies for hepatocellular carcinoma

Carcinogenesis(2023)10.1093/carcin/bgad052

N/A

0DataRank · unranked

28 citations

Changqing Xie, Donna Mabry Hrones, Shadin Ghabra, Tim F. Greten, Cecilia Monge +1 more

Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years

Cancer Medicine(2023)10.1002/cam4.6814

N/A

0DataRank · unranked

21 citations

Tim F. Greten, Cecilia Monge

Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101052

N/A

0DataRank · unranked

31 citations

Erica C. Pehrsson, Aiwu Ruth He, Lipika Goyal, Robin Kate Kelley, Hien Dang +26 more

Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States

Journal of Hepatocellular Carcinoma(2023)10.2147/jhc.s412446

N/A

0DataRank · unranked

14 citations

J. Alberto Maldonado, Katherine A. McGlynn, Tim F. Greten, Cecilia Monge